These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology. Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717 [Abstract] [Full Text] [Related]
8. Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Singer OC, Berkefeld J, Lorenz MW, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T, MR Stroke Study Group Investigators. Cerebrovasc Dis; 2009 Aug; 27(4):368-74. PubMed ID: 19218803 [Abstract] [Full Text] [Related]
9. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A, Dzialowski I, Koch R, Gahn G. J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668 [Abstract] [Full Text] [Related]
13. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome. Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA. Cerebrovasc Dis; 2012 Sep 15; 33(2):135-40. PubMed ID: 22179586 [Abstract] [Full Text] [Related]
14. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabín J. Stroke; 2004 Sep 15; 35(9):2123-7. PubMed ID: 15243150 [Abstract] [Full Text] [Related]